Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Faculty Members have conducted research related to the The Relationship Between Social Support and Family Functioning Among Married Multiple Sclerosis Patients in Iran With the Mediating Role of Spiritual Experiences and Moral Foundations
Sharareh Eskandarieh
Sharareh Eskandarieh

Assistant Professor of Epidemiology

Multiple Sclerosis Research Center

Tehran University of Medical Sciences

All Documents
1. Clinical and Imaging Features of Familial and Sporadic Multiple Sclerosis, Caspian Journal of Neurological Sciences (2025)
2. Environmental Risk Factors of Late-Onset Multiple Sclerosis: A Population-Based Case-Control Study, Journal of Clinical Neuroscience (2025)
3. Scientists Collaboration for Science Development and Peace: Usern View, Acta Medica Iranica (2025)
4. Suicidal Ideation in Patients With Multiple Sclerosis and Its Association With Clinical and Demographic Characteristics, Brain and Behavior (2025)
5. The Coincidence of Multiple Sclerosis and Primary Vasculitis; From the Bench of Pathology to the Bedside of Treatment: A Systematic Review of Case Reports, Neurological Sciences (2025)
6. A National Registry-Based Study of Ethnic Differences in People With Multiple Sclerosis in Iran, Clinical Neurology and Neurosurgery (2024)
7. A National Registry-Based Study of Ethnic Differences in People With Multiple Sclerosis in Iran, Clinical Neurology and Neurosurgery (2024)
8. Consanguineous Marriage Among Familial Multiple Sclerosis Subjects: A National Registry-Based Study, Heliyon (2024)
9. Consanguineous Marriage Among Familial Multiple Sclerosis Subjects: A National Registry-Based Study, Heliyon (2024)
10. Effect of Ginseng on Fatigue Related to Neuromyelitis Optica Spectrum Disorder: A Double-Blinded Randomized Controlled Clinical Trial, Caspian Journal of Internal Medicine (2024)
11. Global Age-Sex-Specific Mortality, Life Expectancy, and Population Estimates in 204 Countries and Territories and 811 Subnational Locations, 1950–2021, and the Impact of the Covid-19 Pandemic: A Comprehensive Demographic Analysis for the Global Burden of Disease Study 2021, The Lancet (2024)
12. Global Age-Sex-Specific Mortality, Life Expectancy, and Population Estimates in 204 Countries and Territories and 811 Subnational Locations, 1950–2021, and the Impact of the Covid-19 Pandemic: A Comprehensive Demographic Analysis for the Global Burden of Disease Study 2021, The Lancet (2024)
13. Global Burden of 288 Causes of Death and Life Expectancy Decomposition in 204 Countries and Territories and 811 Subnational Locations, 1990–2021: A Systematic Analysis for the Global Burden of Disease Study 2021, The Lancet (2024)
14. Global Burden of 288 Causes of Death and Life Expectancy Decomposition in 204 Countries and Territories and 811 Subnational Locations, 1990–2021: A Systematic Analysis for the Global Burden of Disease Study 2021, The Lancet (2024)
15. Global Fertility in 204 Countries and Territories, 1950–2021, With Forecasts to 2100: A Comprehensive Demographic Analysis for the Global Burden of Disease Study 2021, The Lancet (2024)
16. Global Fertility in 204 Countries and Territories, 1950–2021, With Forecasts to 2100: A Comprehensive Demographic Analysis for the Global Burden of Disease Study 2021, The Lancet (2024)
17. Global, Regional, and National Burden of Disorders Affecting the Nervous System, 1990–2021: A Systematic Analysis for the Global Burden of Disease Study 2021, The Lancet Neurology (2024)
18. Global, Regional, and National Burden of Disorders Affecting the Nervous System, 1990–2021: A Systematic Analysis for the Global Burden of Disease Study 2021, The Lancet Neurology (2024)
19. Global, Regional, and National Burden of Injuries, and Burden Attributable to Injuries Risk Factors, 1990 to 2019: Results From the Global Burden of Disease Study 2019, Public Health (2024)
20. Global, Regional, and National Burden of Neck Pain, 1990–2020, and Projections to 2050: A Systematic Analysis of the Global Burden of Disease Study 2021, The Lancet Rheumatology (2024)
21. Global, Regional, and National Burden of Neck Pain, 1990–2020, and Projections to 2050: A Systematic Analysis of the Global Burden of Disease Study 2021, The Lancet Rheumatology (2024)
22. Investigating the Role of Circulating Tumor Cells in Gastric Cancer: A Comprehensive Systematic Review and Meta-Analysis, Clinical and Experimental Medicine (2024)
23. Investigation of Pregnancy Tendency, Reproductive Characteristics, and Disability in Women With Multiple Sclerosis: A Secondary Data Analysis of the National Registry in Iran, Current Journal of Neurology (2024)
24. Investigation of Pregnancy Tendency, Reproductive Characteristics, and Disability in Women With Multiple Sclerosis: A Secondary Data Analysis of the National Registry in Iran, Current Journal of Neurology (2024)
25. Lifetime Exposure to Smoking and Substance Abuse May Be Associated With Late-Onset Multiple Sclerosis: A Population-Based Case-Control Study, BMC Neurology (2024)
26. Neuromyelitis Optica Spectrum Disorders Registry System in Iran: Validity of Data Sets, Multiple Sclerosis and Related Disorders (2024)
27. Prediction of Novel Biomarkers for Gastric Intestinal Metaplasia and Gastric Adenocarcinoma Using Bioinformatics Analysis, Heliyon (2024)
28. Progressive Multiple Sclerosis Patients Requiring Special Attention As a Group at Risk for Coronavirus Infection, Basic and Clinical Neuroscience (2024)
29. Response Inhibition, Attention and Processing Speed in Male Athlete and Non-Athlete Adolescents, Caspian Journal of Neurological Sciences (2024)
30. The Effect of Crocin-Selenium Nanoparticles on the Cognition and Oxidative Stress Markers of Multiple Sclerosis Patients: A Randomized Triple-Blinded Placebo-Controlled Clinical Trial, BioMetals (2024)
31. Time Interval Between the Onset of Symptoms and Diagnosis of Multiple Sclerosis and the Influential Factors: A National Registry-Based Study, Clinical Neurology and Neurosurgery (2024)
32. Time Interval Between the Onset of Symptoms and Diagnosis of Multiple Sclerosis and the Influential Factors: A National Registry-Based Study, Clinical Neurology and Neurosurgery (2024)
33. Association of Body Mass Index and Physical Activity With Fatigue, Depression, and Anxiety Among Iranian Patients With Multiple Sclerosis, Frontiers in Neurology (2023)
34. Burden of Breast Cancer and Attributable Risk Factors in the North Africa and Middle East Region, 1990–2019: A Systematic Analysis for the Global Burden of Disease Study 2019, Frontiers in Oncology (2023)
35. Burden of Breast Cancer and Attributable Risk Factors in the North Africa and Middle East Region, 1990–2019: A Systematic Analysis for the Global Burden of Disease Study 2019, Frontiers in Oncology (2023)
36. Challenges of Patients With Multiple Sclerosis in Receiving Health Care Services in Iran, Current Journal of Neurology (2023)
37. Comparison of Side Effects of the Dose-1 of Astrazeneca and Sinopharm Vaccines in Patients With Multiple Sclerosis in Kermanshah, Iran (2021), Current Journal of Neurology (2023)
38. Covid-19 and Its Implications on the Clinico-Radiological Course of Multiple Sclerosis: A Case–Control Study; [Covid-19 Y Sus Implicaciones En El Curso Clinico-Radiologico De La Esclerosis Multiple: Un Estudio De Casos Y Controles], Medicina Clinica (2023)
39. Economic and Social Standing of Individuals in Iran Diagnosed With Multiple Sclerosis, Archives of Iranian Medicine (2023)
40. Economic and Social Standing of Individuals in Iran Diagnosed With Multiple Sclerosis, Archives of Iranian Medicine (2023)
41. Epidemiological Parameters of Multiple Sclerosis in Chaharmahal and Bakhtiari Province, Iran, Current Journal of Neurology (2023)
42. Factors Associated With the Number of Months of Delaying in Multiple Sclerosis Diagnosis: Comparison of Count Regression Models, Current Journal of Neurology (2023)
43. Follow-Up of Patients With Multiple Sclerosis After Covid-19 Vaccination With Sinopharm Vaccine, Caspian Journal of Neurological Sciences (2023)
44. Global Investments in Pandemic Preparedness and Covid-19: Development Assistance and Domestic Spending on Health Between 1990 and 2026, The Lancet Global Health (2023)
45. Global Investments in Pandemic Preparedness and Covid-19: Development Assistance and Domestic Spending on Health Between 1990 and 2026, The Lancet Global Health (2023)
46. Global, Regional, and National Burden of Low Back Pain, 1990–2020, Its Attributable Risk Factors, and Projections to 2050: A Systematic Analysis of the Global Burden of Disease Study 2021, The Lancet Rheumatology (2023)
47. Global, Regional, and National Burden of Low Back Pain, 1990–2020, Its Attributable Risk Factors, and Projections to 2050: A Systematic Analysis of the Global Burden of Disease Study 2021, The Lancet Rheumatology (2023)
48. Global, Regional, and National Burden of Spinal Cord Injury, 1990–2019: A Systematic Analysis for the Global Burden of Disease Study 2019, The Lancet Neurology (2023)
49. Late-Onset Multiple Sclerosis in Iran: A Report on Demographic and Disease Characteristics, Multiple Sclerosis and Related Disorders (2023)
50. Late-Onset Multiple Sclerosis in Iran: A Report on Demographic and Disease Characteristics, Multiple Sclerosis and Related Disorders (2023)
51. Side Effects of First and Second Doses of Inactivated Covid-19 Vaccine in Multiple Sclerosis, Caspian Journal of Neurological Sciences (2023)
52. The Effects of Different Types of Smoking on Recovery From Attack in Hospitalized Multiple Sclerosis Patients, Clinical Neurology and Neurosurgery (2023)
53. The Incidence and Prevalence of Crude and Familial Multiple Sclerosis in Tehran, Iran in 2021, Neurological Sciences (2023)
54. The National Multiple Sclerosis Registry System of Iran (Nmsri): Aspects and Methodological Dimensions, Multiple Sclerosis and Related Disorders (2023)
55. The Prevalence of Multiple Sclerosis in Tehran, Iran, in 2020, Current Journal of Neurology (2023)
56. The Unfinished Agenda of Communicable Diseases Among Children and Adolescents Before the Covid-19 Pandemic, 1990–2019: A Systematic Analysis of the Global Burden of Disease Study 2019, The Lancet (2023)
57. The Unfinished Agenda of Communicable Diseases Among Children and Adolescents Before the Covid-19 Pandemic, 1990–2019: A Systematic Analysis of the Global Burden of Disease Study 2019, The Lancet (2023)
58. Waterpipe and Cigarette Smoking and Drug and Alcohol Consumption, and the Risk of Primary Progressive Multiple Sclerosis: A Population-Based Case-Control Study, Current Journal of Neurology (2023)
59. A Report of Multiple Sclerosis Registry in Mazandaran Province 2019-2021, Journal of Mazandaran University of Medical Sciences (2022)
60. Adolescent Transport and Unintentional Injuries: A Systematic Analysis Using the Global Burden of Disease Study 2019, The Lancet Public Health (2022)
61. Adolescent Transport and Unintentional Injuries: A Systematic Analysis Using the Global Burden of Disease Study 2019, The Lancet Public Health (2022)
62. Assessing Performance of the Healthcare Access and Quality Index, Overall and by Select Age Groups, for 204 Countries and Territories, 1990–2019: A Systematic Analysis From the Global Burden of Disease Study 2019, The Lancet Global Health (2022)
63. Assessing Performance of the Healthcare Access and Quality Index, Overall and by Select Age Groups, for 204 Countries and Territories, 1990–2019: A Systematic Analysis From the Global Burden of Disease Study 2019, The Lancet Global Health (2022)
64. Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life Years for 29 Cancer Groups From 2010 to 2019 a Systematic Analysis for the Global Burden of Disease Study 2019, JAMA Oncology (2022)
65. Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life Years for 29 Cancer Groups From 2010 to 2019 a Systematic Analysis for the Global Burden of Disease Study 2019, JAMA Oncology (2022)
66. Characteristics of Covid-19 in Patients With Multiple Sclerosis, Multiple Sclerosis and Related Disorders (2022)
67. Characteristics of Covid-19 in Patients With Multiple Sclerosis, Multiple Sclerosis and Related Disorders (2022)
68. Depression, Anxiety, and Fear of Covid-19 in Patients With Multiple Sclerosis in Pandemic Era: A Cross-Sectional Study, Neurological Sciences (2022)
69. Determining the Effect of Sun Exposure and Physical Activity on the Incidence of Primary Progressive Multiple Sclerosis, Tehran University Medical Journal (2022)
70. Effect of Rituximab on the Cognitive Impairment in Patients With Secondary Progressive Multiple Sclerosis, Caspian Journal of Internal Medicine (2022)
71. Epidemiology of Familial Multiple Sclerosis in Iran: A National Registry-Based Study, BMC Neurology (2022)
72. Epidemiology of Familial Multiple Sclerosis in Iran: A National Registry-Based Study, BMC Neurology (2022)
73. Estimates, Trends, and Drivers of the Global Burden of Type 2 Diabetes Attributable to Pm2·5 Air Pollution, 1990–2019: An Analysis of Data From the Global Burden of Disease Study 2019, The Lancet Planetary Health (2022)
74. Estimation of the Global Prevalence of Dementia in 2019 and Forecasted Prevalence in 2050: An Analysis for the Global Burden of Disease Study 2019, The Lancet Public Health (2022)
75. Global Assessment of Characteristics of Multiple Sclerosis Registries; a Systematic Review, Multiple Sclerosis and Related Disorders (2022)
76. Global, Regional, and National Burden of Hepatitis B, 1990–2019: A Systematic Analysis for the Global Burden of Disease Study 2019, The Lancet Gastroenterology and Hepatology (2022)
77. Global, Regional, and National Burden of Hepatitis B, 1990–2019: A Systematic Analysis for the Global Burden of Disease Study 2019, The Lancet Gastroenterology and Hepatology (2022)
78. Increasing Incidence and Male to Female Sex Ratio of Multiple Sclerosis in Tehran, Iran: A Population-Based Study, Iranian Journal of Public Health (2022)
79. Injury Burden in Individuals Aged 50 Years or Older in the Eastern Mediterranean Region, 1990–2019: A Systematic Analysis From the Global Burden of Disease Study 2019, The Lancet Healthy Longevity (2022)
80. Injury Burden in Individuals Aged 50 Years or Older in the Eastern Mediterranean Region, 1990–2019: A Systematic Analysis From the Global Burden of Disease Study 2019, The Lancet Healthy Longevity (2022)
81. Late-Onset Neuromyelitis Optica Spectrum Disorder: A Case Series From Iran, Revue Neurologique (2022)
82. Mapping Age- and Sex-Specific Hiv Prevalence in Adults in Sub-Saharan Africa, 2000–2018, BMC Medicine (2022)
83. Mapping Development and Health Effects of Cooking With Solid Fuels in Low-Income and Middle-Income Countries, 2000–18: A Geospatial Modelling Study, The Lancet Global Health (2022)
84. Neonate, Infant, and Child Mortality in North Africa and Middle East by Cause: An Analysis for the Global Burden of Disease Study 2019, Archives of Iranian Medicine (2022)
85. Neonate, Infant, and Child Mortality in North Africa and Middle East by Cause: An Analysis for the Global Burden of Disease Study 2019, Archives of Iranian Medicine (2022)
86. Outcomes of Astrazeneca Vaccine for Relapse and Covid-19 Infection in People With Multiple Sclerosis; [پیامدهاي واکسن آسترازنکا در ابتلا به کووید- 19 و عود در افراد مبتلا به مالتیپل اسکلروزیس], Tehran University Medical Journal (2022)
87. Population-Level Risks of Alcohol Consumption by Amount, Geography, Age, Sex, and Year: A Systematic Analysis for the Global Burden of Disease Study 2020, The Lancet (2022)
88. Population-Level Risks of Alcohol Consumption by Amount, Geography, Age, Sex, and Year: A Systematic Analysis for the Global Burden of Disease Study 2020, The Lancet (2022)
89. Prescription Trends of Disease-Modifying Treatments for Multiple Sclerosis in Iran Over the Past 30 Years, Multiple Sclerosis and Related Disorders (2022)
90. Prescription Trends of Disease-Modifying Treatments for Multiple Sclerosis in Iran Over the Past 30 Years, Multiple Sclerosis and Related Disorders (2022)
91. Prevalence of Multiple Sclerosis and Its Clinical and Demographic Characteristics in Kurdish Populations in Western Iran (2020), Multiple Sclerosis and Related Disorders (2022)
92. Research Paper: Covid-19 and Its Outcomes in Multiple Sclerosis Patients, Caspian Journal of Neurological Sciences (2022)
93. The Global Burden of Adolescent and Young Adult Cancer in 2019: A Systematic Analysis for the Global Burden of Disease Study 2019, The Lancet Oncology (2022)
94. The Global Burden of Adolescent and Young Adult Cancer in 2019: A Systematic Analysis for the Global Burden of Disease Study 2019, The Lancet Oncology (2022)
95. The Global Burden of Cancer Attributable to Risk Factors, 2010–19: A Systematic Analysis for the Global Burden of Disease Study 2019, The Lancet (2022)
96. The Global Burden of Cancer Attributable to Risk Factors, 2010–19: A Systematic Analysis for the Global Burden of Disease Study 2019, The Lancet (2022)
97. Anemia Prevalence in Women of Reproductive Age in Low- and Middle-Income Countries Between 2000 and 2018, Nature Medicine (2021)
98. Anemia Prevalence in Women of Reproductive Age in Low- and Middle-Income Countries Between 2000 and 2018, Nature Medicine (2021)
99. Burden of Transport-Related Injuries in the Eastern Mediterranean Region: A Systematic Analysis for the Global Burden of Disease Study 2017, Archives of Iranian Medicine (2021)
100. Can Pulse Steroid Therapy Increase the Risk of Infection by Covid-19 in Patients With Multiple Sclerosis?, Clinical Neurology and Neurosurgery (2021)
101. Causes of Blindness and Vision Impairment in 2020 and Trends Over 30 Years, and Prevalence of Avoidable Blindness in Relation to Vision 2020: The Right to Sight: An Analysis for the Global Burden of Disease Study, The Lancet Global Health (2021)
102. Dietary Risk Factors of Primary Progressive Multiple Sclerosis: A Population-Based Case-Control Study, Multiple Sclerosis and Related Disorders (2021)
103. Economic Sanctions Against Iran As an Important Factor in Threatening the Health of Patients With Multiple Sclerosis, Current Journal of Neurology (2021)
104. Environmental Risk Factors of Multiple Sclerosis in the Middle East and North Africa Region: A Systematic Review, Current Journal of Neurology (2021)
105. Explaining the Individual Challenges of Women Affected by Neuromyelitis Optica and Multiple Sclerosis: A Comparative Content Analysis Study, Clinical Neurology and Neurosurgery (2021)
106. Global Mortality From Dementia: Application of a Newmethod and Results From the Global Burden of Disease Study 2019, Alzheimer's and Dementia: Translational Research and Clinical Interventions (2021)
107. Global, Regional, and National Mortality Among Young People Aged 10–24 Years, 1950–2019: A Systematic Analysis for the Global Burden of Disease Study 2019, The Lancet (2021)
108. Global, Regional, and National Mortality Among Young People Aged 10–24 Years, 1950–2019: A Systematic Analysis for the Global Burden of Disease Study 2019, The Lancet (2021)
109. Global, Regional, and National Sex-Specific Burden and Control of the Hiv Epidemic, 1990–2019, for 204 Countries and Territories: The Global Burden of Diseases Study 2019, The Lancet HIV (2021)
110. Implementing Coronavirus Disease 2019 Scale-Up Registry Protocol in National Multiple Sclerosis Registry System of Iran, Current Journal of Neurology (2021)
111. Mapping Routine Measles Vaccination in Low- and Middle-Income Countries, Nature (2021)
112. Mapping Routine Measles Vaccination in Low- and Middle-Income Countries, Nature (2021)
113. Measuring Routine Childhood Vaccination Coverage in 204 Countries and Territories, 1980–2019: A Systematic Analysis for the Global Burden of Disease Study 2020, Release 1, The Lancet (2021)
114. Medical History Risk Factors in Primary Progressive Multiple Sclerosis: A Case-Control Study, Current Journal of Neurology (2021)
115. Multiple Sclerosis Projection in Tehran, Iran Using Bayesian Structural Time Series, BMC Neurology (2021)
116. Prevalence of Multiple Sclerosis and Its Risks in Tehran, Iran, in 2019, Neurological Sciences (2021)
117. Stressful Life Events and the Risk of Primary Progressive Multiple Sclerosis: A Population-Based Case-Control Study, Multiple Sclerosis and Related Disorders (2021)
118. Subjective Global Assessment of Malnutrition and Dysphagia Effect on the Clinical and Para-Clinical Outcomes in Elderly Ischemic Stroke Patients: A Community-Based Study, BMC Neurology (2021)
119. Subnational Mapping of Hiv Incidence and Mortality Among Individuals Aged 15–49 Years in Sub-Saharan Africa, 2000–18: A Modelling Study, The Lancet HIV (2021)
120. Subnational Mapping of Hiv Incidence and Mortality Among Individuals Aged 15–49 Years in Sub-Saharan Africa, 2000–18: A Modelling Study, The Lancet HIV (2021)
121. Tracking Development Assistance for Health and for Covid-19: A Review of Development Assistance, Government, Out-Of-Pocket, and Other Private Spending on Health for 204 Countries and Territories, 1990–2050, The Lancet (2021)
122. Tracking Development Assistance for Health and for Covid-19: A Review of Development Assistance, Government, Out-Of-Pocket, and Other Private Spending on Health for 204 Countries and Territories, 1990–2050, The Lancet (2021)
123. Use of Multidimensional Item Response Theory Methods for Dementia Prevalence Prediction: An Example Using the Health and Retirement Survey and the Aging, Demographics, and Memory Study, BMC Medical Informatics and Decision Making (2021)
124. Author Correction: Mapping Local Patterns of Childhood Overweight and Wasting in Low- and Middle-Income Countries Between 2000 and 2017 (Nature Medicine, (2020), 26, 5, (750-759), 10.1038/S41591-020-0807-6), Nature Medicine (2020)
125. Author Correction: Mapping Local Patterns of Childhood Overweight and Wasting in Low- and Middle-Income Countries Between 2000 and 2017 (Nature Medicine, (2020), 26, 5, (750-759), 10.1038/S41591-020-0807-6), Nature Medicine (2020)
126. Burden of Injury Along the Development Spectrum: Associations Between the Socio-Demographic Index and Disability-Adjusted Life Year Estimates From the Global Burden of Disease Study 2017, Injury Prevention (2020)
127. Burden of Musculoskeletal Disorders in Iran During 1990–2017: Estimates From the Global Burden of Disease Study 2017, Archives of Osteoporosis (2020)
128. Department of Error: Mapping Geographical Inequalities in Childhood Diarrhoeal Morbidity and Mortality in Low-Income and Middle-Income Countries, 2000–17: Analysis for the Global Burden of Disease Study 2017 (The Lancet (2020) 395(10239) (1779–1801), (S0140673620301148), (10.1016/S0140-6736(20)30114-8)), The Lancet (2020)
129. Department of Error: Mapping Geographical Inequalities in Childhood Diarrhoeal Morbidity and Mortality in Low-Income and Middle-Income Countries, 2000–17: Analysis for the Global Burden of Disease Study 2017 (The Lancet (2020) 395(10239) (1779–1801), (S0140673620301148), (10.1016/S0140-6736(20)30114-8)), The Lancet (2020)
130. Epidemiology of Familial Multiple Sclerosis: A Population-Based Study in Tehran During 1999–2018, Multiple Sclerosis and Related Disorders (2020)
131. Epidemiology of Neuromyelitis Optica Spectrum Disorder in Tehran, Iran: The Prevalence, Baseline Characteristics, and Clinical Aspects, Neurological Sciences (2020)
132. Estimating Global Injuries Morbidity and Mortality: Methods and Data Used in the Global Burden of Disease 2017 Study, Injury Prevention (2020)
133. Estimating Global Injuries Morbidity and Mortality: Methods and Data Used in the Global Burden of Disease 2017 Study, Injury Prevention (2020)
134. Evidence of an Increased Prevalence of Multiple Sclerosis: A Population-Based Study of Tehran Registry During 1999-2018, BMC Neurology (2020)
135. Five Insights From the Global Burden of Disease Study 2019, The Lancet (2020)
136. Five Insights From the Global Burden of Disease Study 2019, The Lancet (2020)
137. Global Age-Sex-Specific Fertility, Mortality, Healthy Life Expectancy (Hale), and Population Estimates in 204 Countries and Territories, 1950–2019: A Comprehensive Demographic Analysis for the Global Burden of Disease Study 2019, The Lancet (2020)
138. Global Age-Sex-Specific Fertility, Mortality, Healthy Life Expectancy (Hale), and Population Estimates in 204 Countries and Territories, 1950–2019: A Comprehensive Demographic Analysis for the Global Burden of Disease Study 2019, The Lancet (2020)
139. Global Burden of 369 Diseases and Injuries in 204 Countries and Territories, 1990–2019: A Systematic Analysis for the Global Burden of Disease Study 2019, The Lancet (2020)
140. Global Burden of 369 Diseases and Injuries in 204 Countries and Territories, 1990–2019: A Systematic Analysis for the Global Burden of Disease Study 2019, The Lancet (2020)
141. Global Burden of 87 Risk Factors in 204 Countries and Territories, 1990–2019: A Systematic Analysis for the Global Burden of Disease Study 2019, The Lancet (2020)
142. Global Burden of 87 Risk Factors in 204 Countries and Territories, 1990–2019: A Systematic Analysis for the Global Burden of Disease Study 2019, The Lancet (2020)
143. Global Injury Morbidity and Mortality From 1990 to 2017: Results From the Global Burden of Disease Study 2017, Injury Prevention (2020)
144. Global Injury Morbidity and Mortality From 1990 to 2017: Results From the Global Burden of Disease Study 2017, Injury Prevention (2020)
145. Health Sector Spending and Spending on Hiv/Aids, Tuberculosis, and Malaria, and Development Assistance for Health: Progress Towards Sustainable Development Goal 3, The Lancet (2020)
146. Mapping Geographical Inequalities in Access to Drinking Water and Sanitation Facilities in Low-Income and Middle-Income Countries, 2000-17, The Lancet Global Health (2020)
147. Mapping Geographical Inequalities in Access to Drinking Water and Sanitation Facilities in Low-Income and Middle-Income Countries, 2000-17, The Lancet Global Health (2020)
148. Mapping Geographical Inequalities in Childhood Diarrhoeal Morbidity and Mortality in Low-Income and Middle-Income Countries, 2000-17: Analysis for the Global Burden of Disease Study 2017, The Lancet (2020)
149. Mapping Geographical Inequalities in Childhood Diarrhoeal Morbidity and Mortality in Low-Income and Middle-Income Countries, 2000-17: Analysis for the Global Burden of Disease Study 2017, The Lancet (2020)
150. Mapping Geographical Inequalities in Oral Rehydration Therapy Coverage in Low-Income and Middle-Income Countries, 2000-17, The Lancet Global Health (2020)
151. Mapping Geographical Inequalities in Oral Rehydration Therapy Coverage in Low-Income and Middle-Income Countries, 2000-17, The Lancet Global Health (2020)
152. Mapping Local Patterns of Childhood Overweight and Wasting in Low- and Middle-Income Countries Between 2000 and 2017, Nature Medicine (2020)
153. Mapping Local Patterns of Childhood Overweight and Wasting in Low- and Middle-Income Countries Between 2000 and 2017, Nature Medicine (2020)
154. Measuring Universal Health Coverage Based on an Index of Effective Coverage of Health Services in 204 Countries and Territories, 1990–2019: A Systematic Analysis for the Global Burden of Disease Study 2019, The Lancet (2020)
155. Measuring Universal Health Coverage Based on an Index of Effective Coverage of Health Services in 204 Countries and Territories, 1990–2019: A Systematic Analysis for the Global Burden of Disease Study 2019, The Lancet (2020)
156. Persian Adaptation of Actionable Bladder Symptom Screening Tool Among Patients With Multiple Sclerosis, Journal of Multidisciplinary Healthcare (2020)
157. Stressful Life Events, Socioeconomic Status, and the Risk of Neuromyelitis Optica Spectrum Disorder: A Population-Based Case-Control Study, Multiple Sclerosis and Related Disorders (2020)
158. The Health Burden of Non-Communicable Neurological Disorders in the Usa Between 1990 and 2017, Brain Communications (2020)
159. Erratum: Global, Regional, and National Comparative Risk Assessment of 84 Behavioural, Environmental and Occupational, and Metabolic Risks or Clusters of Risks for 195 Countries and Territories, 1990–2017: A Systematic Analysis for the Global Burden of Disease Study 2017 (The Lancet (2018) 392(10159) (1923–1994), (S0140673618322256), (10.1016/S0140-6736(18)32225-6)), The Lancet (2019)
160. Erratum: Global, Regional, and National Comparative Risk Assessment of 84 Behavioural, Environmental and Occupational, and Metabolic Risks or Clusters of Risks for 195 Countries and Territories, 1990–2017: A Systematic Analysis for the Global Burden of Disease Study 2017 (The Lancet (2018) 392(10159) (1923–1994), (S0140673618322256), (10.1016/S0140-6736(18)32225-6)), The Lancet (2019)
161. Global, Regional, and National Burden of Neurological Disorders, 1990–2016: A Systematic Analysis for the Global Burden of Disease Study 2016, The Lancet Neurology (2019)
162. Global, Regional, and National Burden of Neurological Disorders, 1990–2016: A Systematic Analysis for the Global Burden of Disease Study 2016, The Lancet Neurology (2019)
163. Global, Regional, and National Burden of Suicide Mortality 1990 to 2016: Systematic Analysis for the Global Burden of Disease Study 2016, BMJ (Online) (2019)
164. Global, Regional, and National Burden of Traumatic Brain Injury and Spinal Cord Injury, 1990-2016: A Systematic Analysis for the Global Burden of Disease Study 2016, The Lancet Neurology (2019)
165. Global, Regional, and National Incidence, Prevalence, and Mortality of Hiv, 1980-2017, and Forecasts to 2030, for 195 Countries and Territories: A Systematic Analysis for the Global Burden of Diseases, Injuries, and Risk Factors Study 2017, The Lancet HIV (2019)
166. Mapping 123 Million Neonatal, Infant and Child Deaths Between 2000 and 2017, Nature (2019)
167. Mapping 123 Million Neonatal, Infant and Child Deaths Between 2000 and 2017, Nature (2019)
168. Multiple Sclerosis in Tehran: Rising Prevalence Alongside Stabilizing Incidence - True Increase or Enhanced Diagnosis?, Archives of Iranian medicine (2019)
169. Multiple Sclerosis National Registry System in Iran: Validity and Reliability of a Minimum Data Set, Multiple Sclerosis and Related Disorders (2019)
170. Multiple Sclerosis National Registry System in Iran: Validity and Reliability of a Minimum Data Set, Multiple Sclerosis and Related Disorders (2019)
171. Past, Present, and Future of Global Health Financing: A Review of Development Assistance, Government, Out-Of-Pocket, and Other Private Spending on Health for 195 Countries, 1995-2050, The Lancet (2019)
172. Pediatric Multiple Sclerosis and Its Familial Recurrence: A Population Based Study (1999–2017), Multiple Sclerosis and Related Disorders (2019)
173. Anti-Jc Virus Antibody Sera Positivity and Index Value Among Patients With Multiple Sclerosis May Be Correlated With Age, Sex, and Area of Residence, Journal of NeuroVirology (2018)
174. Environmental Risk Factors in Neuromyelitis Optica Spectrum Disorder: A Case–Control Study, Acta Neurologica Belgica (2018)
175. Erratum: Global, Regional, and National Age-Sex-Specific Mortality for 282 Causes of Death in 195 Countries and Territories, 1980–2017: A Systematic Analysis for the Global Burden of Disease Study 2017 (The Lancet (2018) 392(10159) (1736–1788)(S0140673618322037)(10.1016/S0140-6736(18)32203-7)), The Lancet (2018)
176. Erratum: Global, Regional, and National Age-Sex-Specific Mortality for 282 Causes of Death in 195 Countries and Territories, 1980–2017: A Systematic Analysis for the Global Burden of Disease Study 2017 (The Lancet (2018) 392(10159) (1736–1788)(S0140673618322037)(10.1016/S0140-6736(18)32203-7)), The Lancet (2018)
177. Global, Regional, and National Age-Sex-Specific Mortality and Life Expectancy, 1950-2017: A Systematic Analysis for the Global Burden of Disease Study 2017, The Lancet (2018)
178. Global, Regional, and National Age-Sex-Specific Mortality and Life Expectancy, 1950-2017: A Systematic Analysis for the Global Burden of Disease Study 2017, The Lancet (2018)
179. Global, Regional, and National Age-Sex-Specific Mortality for 282 Causes of Death in 195 Countries and Territories, 1980–2017: A Systematic Analysis for the Global Burden of Disease Study 2017, The Lancet (2018)
180. Global, Regional, and National Age-Sex-Specific Mortality for 282 Causes of Death in 195 Countries and Territories, 1980–2017: A Systematic Analysis for the Global Burden of Disease Study 2017, The Lancet (2018)
181. Global, Regional, and National Comparative Risk Assessment of 84 Behavioural, Environmental and Occupational, and Metabolic Risks or Clusters of Risks for 195 Countries and Territories, 1990-2017: A Systematic Analysis for the Global Burden of Disease Study 2017, The Lancet (2018)
182. Global, Regional, and National Comparative Risk Assessment of 84 Behavioural, Environmental and Occupational, and Metabolic Risks or Clusters of Risks for 195 Countries and Territories, 1990-2017: A Systematic Analysis for the Global Burden of Disease Study 2017, The Lancet (2018)
183. Global, Regional, and National Disability-Adjusted Life-Years (Dalys) for 359 Diseases and Injuries and Healthy Life Expectancy (Hale) for 195 Countries and Territories, 1990-2017: A Systematic Analysis for the Global Burden of Disease Study 2017, The Lancet (2018)
184. Global, Regional, and National Disability-Adjusted Life-Years (Dalys) for 359 Diseases and Injuries and Healthy Life Expectancy (Hale) for 195 Countries and Territories, 1990-2017: A Systematic Analysis for the Global Burden of Disease Study 2017, The Lancet (2018)
185. Global, Regional, and National Incidence, Prevalence, and Years Lived With Disability for 354 Diseases and Injuries for 195 Countries and Territories, 1990-2017: A Systematic Analysis for the Global Burden of Disease Study 2017, The Lancet (2018)
186. Global, Regional, and National Incidence, Prevalence, and Years Lived With Disability for 354 Diseases and Injuries for 195 Countries and Territories, 1990-2017: A Systematic Analysis for the Global Burden of Disease Study 2017, The Lancet (2018)
187. Hla-Drb1 Polymorphism and Susceptibility to Multiple Sclerosis in the Middle East North Africa Region: A Systematic Review and Meta-Analysis, Journal of Neuroimmunology (2018)
188. Increasing Prevalence of Familial Recurrence of Multiple Sclerosis in Iran: A Population Based Study of Tehran Registry 1999-2015, BMC Neurology (2018)
189. Measuring Performance on the Healthcare Access and Quality Index for 195 Countries and Territories and Selected Subnational Locations: A Systematic Analysis From the Global Burden of Disease Study 2016, The Lancet (2018)
190. Measuring Performance on the Healthcare Access and Quality Index for 195 Countries and Territories and Selected Subnational Locations: A Systematic Analysis From the Global Burden of Disease Study 2016, The Lancet (2018)
191. Measuring Progress From 1990 to 2017 and Projecting Attainment to 2030 of the Health-Related Sustainable Development Goals for 195 Countries and Territories: A Systematic Analysis for the Global Burden of Disease Study 2017, The Lancet (2018)
192. Measuring Progress From 1990 to 2017 and Projecting Attainment to 2030 of the Health-Related Sustainable Development Goals for 195 Countries and Territories: A Systematic Analysis for the Global Burden of Disease Study 2017, The Lancet (2018)
193. Population and Fertility by Age and Sex for 195 Countries and Territories, 1950–2017: A Systematic Analysis for the Global Burden of Disease Study 2017, The Lancet (2018)
194. Population and Fertility by Age and Sex for 195 Countries and Territories, 1950–2017: A Systematic Analysis for the Global Burden of Disease Study 2017, The Lancet (2018)
195. The Prevalence, Incidence and Familial Recurrence of Multiple Sclerosis in Tehran, Iran, Multiple Sclerosis and Related Disorders (2018)
196. Comparing Epidemiology and Baseline Characteristic of Multiple Sclerosis and Neuromyelitis Optica: A Case-Control Study, Multiple Sclerosis and Related Disorders (2017)
197. Cyp17 Mspa1 Gene Polymorphism and Breast Cancer Patients According to Age of Onset in Cancer Institute of Iran, Iranian Journal of Public Health (2017)
198. Global, Regional, and National Age-Sex Specific Mortality for 264 Causes of Death, 1980–2016: A Systematic Analysis for the Global Burden of Disease Study 2016, The Lancet (2017)
199. Global, Regional, and National Burden of Neurological Disorders During 1990–2015: A Systematic Analysis for the Global Burden of Disease Study 2015, The Lancet Neurology (2017)
200. Global, Regional, and National Comparative Risk Assessment of 84 Behavioural, Environmental and Occupational, and Metabolic Risks or Clusters of Risks, 1990-2016: A Systematic Analysis for the Global Burden of Disease Study 2016, The Lancet (2017)
201. Global, Regional, and National Incidence, Prevalence, and Years Lived With Disability for 328 Diseases and Injuries for 195 Countries, 1990-2016: A Systematic Analysis for the Global Burden of Disease Study 2016, The Lancet (2017)
202. Global, Regional, and National Under-5 Mortality, Adult Mortality, Age-Specific Mortality, and Life Expectancy, 1970-2016: A Systematic Analysis for the Global Burden of Disease Study 2016, The Lancet (2017)
203. Measuring Progress and Projecting Attainment on the Basis of Past Trends of the Health-Related Sustainable Development Goals in 188 Countries: An Analysis From the Global Burden of Disease Study 2016, The Lancet (2017)
204. Neuromyelitis Optica Spectrum Disorders in Iran, Multiple Sclerosis and Related Disorders (2017)
205. Prevalence and Incidence of Multiple Sclerosis in Tehran, Iran, Iranian Journal of Public Health (2017)
206. Melanoma in Iran: A Retrospective 10-Year Study, Asian Pacific Journal of Cancer Prevention (2016)
207. Multiple Sclerosis Epidemiology in East Asia, South East Asia and South Asia: A Systematic Review, Neuroepidemiology (2016)